IBDEI1DZ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23127,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,23127,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,23128,0)
 ;;=C16.9^^110^1097^23
 ;;^UTILITY(U,$J,358.3,23128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23128,1,3,0)
 ;;=3^Malig Neop Stomach,Unspec
 ;;^UTILITY(U,$J,358.3,23128,1,4,0)
 ;;=4^C16.9
 ;;^UTILITY(U,$J,358.3,23128,2)
 ;;=^5000923
 ;;^UTILITY(U,$J,358.3,23129,0)
 ;;=C20.^^110^1097^22
 ;;^UTILITY(U,$J,358.3,23129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23129,1,3,0)
 ;;=3^Malig Neop Rectum
 ;;^UTILITY(U,$J,358.3,23129,1,4,0)
 ;;=4^C20.
 ;;^UTILITY(U,$J,358.3,23129,2)
 ;;=^267090
 ;;^UTILITY(U,$J,358.3,23130,0)
 ;;=C43.9^^110^1097^5
 ;;^UTILITY(U,$J,358.3,23130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23130,1,3,0)
 ;;=3^Malig Melanoma Skin,Unspec
 ;;^UTILITY(U,$J,358.3,23130,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,23130,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,23131,0)
 ;;=C22.9^^110^1097^20
 ;;^UTILITY(U,$J,358.3,23131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23131,1,3,0)
 ;;=3^Malig Neop Liver,Unspec as Prim/Second
 ;;^UTILITY(U,$J,358.3,23131,1,4,0)
 ;;=4^C22.9
 ;;^UTILITY(U,$J,358.3,23131,2)
 ;;=^267096
 ;;^UTILITY(U,$J,358.3,23132,0)
 ;;=C32.9^^110^1097^18
 ;;^UTILITY(U,$J,358.3,23132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23132,1,3,0)
 ;;=3^Malig Neop Larynx,Unspec
 ;;^UTILITY(U,$J,358.3,23132,1,4,0)
 ;;=4^C32.9
 ;;^UTILITY(U,$J,358.3,23132,2)
 ;;=^5000956
 ;;^UTILITY(U,$J,358.3,23133,0)
 ;;=C50.911^^110^1097^10
 ;;^UTILITY(U,$J,358.3,23133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23133,1,3,0)
 ;;=3^Malig Neop Breast,Right,Female
 ;;^UTILITY(U,$J,358.3,23133,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,23133,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,23134,0)
 ;;=C50.912^^110^1097^9
 ;;^UTILITY(U,$J,358.3,23134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23134,1,3,0)
 ;;=3^Malig Neop Breast,Left,Female
 ;;^UTILITY(U,$J,358.3,23134,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,23134,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,23135,0)
 ;;=C24.9^^110^1097^6
 ;;^UTILITY(U,$J,358.3,23135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23135,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,23135,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,23135,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,23136,0)
 ;;=C90.00^^110^1097^24
 ;;^UTILITY(U,$J,358.3,23136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23136,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,23136,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,23136,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,23137,0)
 ;;=C85.89^^110^1097^29
 ;;^UTILITY(U,$J,358.3,23137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23137,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma NEC,Extranodal & Solid Organ
 ;;^UTILITY(U,$J,358.3,23137,1,4,0)
 ;;=4^C85.89
 ;;^UTILITY(U,$J,358.3,23137,2)
 ;;=^5001730
 ;;^UTILITY(U,$J,358.3,23138,0)
 ;;=C79.51^^110^1097^32
 ;;^UTILITY(U,$J,358.3,23138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23138,1,3,0)
 ;;=3^Secondary Malig Neop Bone
 ;;^UTILITY(U,$J,358.3,23138,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,23138,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,23139,0)
 ;;=C79.52^^110^1097^31
 ;;^UTILITY(U,$J,358.3,23139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23139,1,3,0)
 ;;=3^Secondary Malig Neop  Bone Marrow
 ;;^UTILITY(U,$J,358.3,23139,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,23139,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,23140,0)
 ;;=C92.00^^110^1097^25
 ;;^UTILITY(U,$J,358.3,23140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23140,1,3,0)
 ;;=3^Myeloblastic Leukemia,Acute,Not in Remission
